New findings from University of Texas, Division of Cardiology describe advances in enzyme research December 7, 2007 Calibre MacroWorld, Dec. 6, 2007 According to recent research published in the journal Cardiovascular Drugs and Therapy, "Atorvastatin protects against ischemia-reperfusion by upregulating Akt and subsequently, endothelial nitric oxide synthase phosphorylation at Ser-1177. However, when given orally, high doses of ATV (10 mg/kg/d) are needed to achieve maximal protective effect in the rat." Saraswathy Manickavasagam and colleagues at UTMB conducted the research. « Back | The Newsroom »